story of the week
Ofatumumab vs Teriflunomide in MS
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ofatumumab Versus Teriflunomide in Multiple Sclerosis
N. Engl. J. Med 2020 Aug 06;383(6)546-557, SL Hauser, A Bar-Or, JA Cohen, G Comi, J Correale, PK Coyle, AH Cross, J de Seze, D Leppert, X Montalban, K Selmaj, H Wiendl, C Kerloeguen, R Willi, B Li, A Kakarieka, D Tomic, A Goodyear, R Pingili, DA Häring, K Ramanathan, M Merschhemke, L KapposFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.